Monthly Archives: March 2020

BYND SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Notifies Beyond Meat, Inc. Shareholders With Losses Exceeding $100K of Class Action and Lead Deadline: March 30, 2020

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Beyond Meat, Inc. ("Beyond Meat" or the Company") (NASDAQ: BYND) and certain of its officers, on behalf of shareholders who purchased Beyond Meat securities between May 2, 2019 and January 27, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site:www.bgandg.com/bynd.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Beyond Meat's termination of its supply agreement with Don Lee Farms constituted a breach of that agreement, thus exposing the Company to foreseeable legal liability and reputational harm; (2) Beyond Meat and certain of its employees had doctored and omitted material information from a food safety consultant's report, which the Company represented as accurate to Don Lee Farms; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/bynd or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Beyond Meat you have until March 30, 2020 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 581962

PAYS SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies Paysign, Inc. Investors of Class Action and Encourages Shareholders with Losses in Excess of $100,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against of Paysign, Inc. ("Paysign" or the "Company") (NASDAQ: PAYS) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Paysign securities between March 12, 2019 and March 15, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/pays.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statementsthat: (1) Paysign's internal control over financial reporting was not effective; (2) Paysign's information technology general controls were not effective; and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/pays or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Paysign you have until May 18, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 582003

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SSL, WBK and MGPI

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Sasol Limited (NYSE:SSL)
Class Period: March 10, 2015 to January 13, 2020
Lead Plaintiff Deadline: April 6, 2020

Throughout the class period, Sasol Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Sasol had conducted insufficient due diligence into, and failed to account for multiple issues with, the Lake Charles Chemicals Project ("LCCP"), as well as the true cost of the project; (ii) construction and operation of the LCCP was consequently plagued by control weaknesses, delays, rising costs, and technical issues; (iii) these issues were exacerbated by Sasol’s top-level management, who engaged in improper and unethical behavior with respect to financial reporting for the LCCP and the project’s oversight; (iv) all the foregoing was reasonably likely to render the LCCP significantly more expensive than disclosed and negatively impact the Company’s financial results; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in SSL: http://www.kleinstocklaw.com/pslra-1/sasol-limited-loss-submission-form?id=5830&from=1

Westpac Banking Corporation (NYSE:WBK)
Class Period: November 11, 2015 to November 19, 2019
Lead Plaintiff Deadline: March 30, 2020

The complaint alleges that throughout the class period Westpac Banking Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) contrary to Australian law, the Company failed to report over 19.5 million international funds transfer instructions to the Australian Transaction Reports and Analysis Centre ("AUSTRAC"); (2) the Company did not appropriately monitor and assess the ongoing money laundering and terrorism financing risks associated with movement of money into and out of Australia; (3) the Westpac did not pass on requisite information about the source of funds to other banks in the transfer chain; (4) despite being aware of the heightened risks, the Company did not carry out appropriate due diligence on transactions in South East Asia and the Philippines that had known financial indicators relating to child exploitation risks; (5) the Company's Anti-Money Laundering and Counter-Terrorism Financing Policy Program was inadequate to identify, mitigate and manage money laundering and terrorism financing risks; and (6) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in WBK: http://www.kleinstocklaw.com/pslra-1/westpac-banking-corporation-loss-submission-form?id=5830&from=1

MGP Ingredients, Inc. (NASDAQ:MGPI)
Class Period: February 27, 2019 to February 25, 2020
Lead Plaintiff Deadline: April 28, 2020

MGP Ingredients, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) MGP had not completed any significant sales of its four-year-old aged whiskey inventory; (b) the Company had been unable to sell its aged whiskey at the price premium represented to investors; (c) a glut of aged whiskey inventory and shifts in consumer behavior had lowered the value of the Company’s aged whiskey inventory and materially impaired its ability to negotiate significant sales on favorable contract terms; and (d) in light of the foregoing, the Company’s FY19 financial forecast lacked a reasonable basis and was materially misleading.

Learn about your recoverable losses in MGPI: http://www.kleinstocklaw.com/pslra-1/mgp-ingredients-inc-loss-submission-form?id=5830&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 582834

LOGC SHAREHOLDER UPDATE: Bronstein, Gewirtz & Grossman, LLC Notifies LogicBio Therapeutics, Inc. Shareholders of Class Action and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against of LogicBio Therapeutics, Inc. ("LogicBio" or the Company") (NASDAQ: LOGC) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired LogicBiosecurities between December 3, 2018 and February 10, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/logc.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statementsthat: (1) LogicBio Therapeutics, Inc.'s behind-schedule and rushed Investigational New Drug ("IND") submission of LB-001 did not answer certain pertinent clinical and nonclinical questions; (2) as a result, the U.S. Food and Drug Administration was likely to hold or deny the IND submission of LB-001 for treatment of methylmalonic acidemia (MMA); and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/logc. or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in LogicBio you have until May 18, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 581998

WBK DEADLINE – Bronstein, Gewirtz & Grossman, LLC Reminds Westpac Banking Corporation Shareholders With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: March 30, 2020

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Westpac Banking Corporation ("Westpac" or the Company") (NYSE: WBK) and certain of its officers, on behalf of shareholders who purchased Westpac securities between November 11, 2015 and November 19, 2019, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/wbk.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) contrary to Australian law, the Company failed to report over 19.5 million international funds transfer instructions to AUSTRAC, Australia's anti money-laundering and terrorism financing regulator; (2) the Company did not appropriately monitor and assess the ongoing money laundering and terrorism financing risks associated with movement of money into and out of Australia; (3) the Company did not pass on requisite information about the source of funds to other banks in the transfer chain; (4) despite being aware of the heightened risks, the Company did not carry out appropriate due diligence on transactions in South East Asia and the Philippines that had known financial indicators relating to child exploitation risks; (5) the Company's AML/CTF Program was inadequate to identify, mitigate and manage money laundering and terrorism financing risks; and (6) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

If you wish to review a copy of the Complaint you can visit the firm's site: www.bgandg.com/wbk or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Westpac you have until March 30, 2020 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 581959

Long-time Surviveware Customer Finds Peace of Mind in Owning a Survival Kit

Loyal Surviveware User Equips Car with Surviveware Survival Kit

Woodbridge, United States – March 27, 2020 /MarketersMedia/

High-quality products and services are the keys to attracting loyal customers and patrons. Without them, it would be impossible to grow one’s business and build a foundation of trust and confidence among its clients. This is why Surviveware, a leading survival and preparedness retailer, has invested in establishing personalized connections and rapport with its customers.

Surviveware has grown its market niche by giving customers a better option for hiking and emergency gear through its growing line of first aid and survival kits. Over the years, the company has sold high-quality, affordable equipment tailored to the unique needs of its target market. With the debut of its highly reliable Survival Kits, the company has seen a drastic increase in the number of individuals who are leveling-up their preparedness game.

Surviveware’s Survival Kits are innovative outdoor packs that combine first aid with two other essential components: hygiene and survival. One’s survival is dependent on these areas; therefore, it’s wise to invest in gear and tools that focus on these areas. This first aid tactical kit combines supplies from these key fields into one handy life-saving pack.

First aid items include a CPR kit, tweezers, trauma shears, splinter probes, bandages, and eye pads, among others. Survival items include a multi-tool, knife, signaling mirror, and flashlight, as well as several other multi-purpose tools. Surviveware’s own biodegradable wet wipes are included within the kit to complete the hygiene section.

All of the provisions are stored inside colored-coded compartments by type and use to make retrieval and replenishment easier. Since everything is labeled, first aid tactical kit users don’t need to dump everything out and sift through it to find what is needed. The labels are also crucial in giving a sense of control to the user.

With such a vast array of provisions, it’s easy to think that there won’t be any space available for adding one’s own set of tools. However, Surviveware made sure that its first aid and survival kit has enough space for personal items, such as prescriptions, inhalers, creams, and an Epi-pen. Kit owners are given the freedom to customize their kits according to their needs and preferences.

The Survival Kit comes with MOLLE-compatible straps, which makes it easier to lock the kit in place and retrieve it when necessary. For emergencies where every second counts, owners can quickly grab and peel this kit off through its Velcro side panel.

The best way to evaluate the effectiveness of a product is to check the feedback of its users. Surviveware has a consistent track record as an emergency and preparedness retailer. In a review written by an Amazon customer, the reviewer mentioned that he is a long-time client of the company, which helped him decide to purchase a first aid and Survival Kit from Surviveware.

“This is a really nice kit. The items seem to be of good quality and a great selection to get you past many minor emergencies. I have other Surviveware items, and they all share the same attention to detail. I like that their kits aren’t thrown together in some cheap plastic box with a red-cross stenciled across the face.

The many…many pockets clearly labeled with fabric labels should be really helpful (not fallen off) in a high-stress situation. Fortunately, I haven’t had to use mine yet, but having it with me in the car provides a peace of mind while driving 3 hrs/day in heavy traffic where anything can happen.”

Stay confident and prepared for any road-related accident by equipping yourself with the right knowledge, presence of mind, and first aid tactical kit on hand. Order your Surviveware Survival Kit today by clicking here.

Contact Info:
Name: Amanda Condry
Email: Send Email
Organization: Surviveware
Phone: 703-910-5188
Website: https://surviveware.com

Source URL: https://marketersmedia.com/long-time-surviveware-customer-finds-peace-of-mind-in-owning-a-survival-kit/88951187

Source: MarketersMedia

Release ID: 88951187

CLASS ACTION UPDATE for WWE, AAN and ANAB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court and further details about the cases can be found at the links provided. There is no cost or obligation to you.

World Wrestling Entertainment, Inc. (NYSE:WWE)
WWE Lawsuit on behalf of: investors who purchased February 7, 2019 – February 5, 2020
Lead Plaintiff Deadline: May 5, 2020
Join the action: https://www.zlk.com/pslra-1/world-wrestling-entertainment-inc-loss-form?wire=3&prid=5829

About the WWE lawsuit: World Wrestling Entertainment, Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: Defendants perpetrated a fraudulent scheme which: (i) deceived the investing public regarding WWE's business and prospects; (ii) artificially inflated the price of WWE Class A common stock; (iii) permitted certain senior executives of WWE to sell more than $282 million worth of their personally held shares at fraud inflated prices; and (iv) caused the public to purchase WWE Class A common stock at artificially inflated prices.

To learn more about the World Wrestling Entertainment, Inc. class action, contact jlevi@levikorsinsky.com.

Aarons, Inc. (NYSE:AAN)
AAN Lawsuit on behalf of: investors who purchased March 2, 2018 – February 19, 2020
Lead Plaintiff Deadline: April 28, 2020
Join the action: https://www.zlk.com/pslra-1/aarons-inc-loss-form?wire=3&prid=5829

About the AAN lawsuit: Aarons, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Aaron's had inadequate disclosure controls, procedures, and compliance measures; (ii) consequently, the operations of Aaron's Progressive Leasing ("Progressive") and Aaron's Business ("AB") segments were in violation of the Federal Trade Commission ("FTC") Act and/or relevant FTC regulations; (iii) consequently, Aaron's earnings from those segments were partially derived from unlawful business practices and were thus unsustainable; (iv) the full extent of Aaron's liability regarding the FTC's investigation into its Progressive and AB segments, Aaron's noncompliance with the FTC Act, and the likely negative consequences of all the foregoing on the Company's financial results; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

To learn more about the Aarons, Inc. class action, contact jlevi@levikorsinsky.com.

AnaptysBio, Inc. (NASDAQ:ANAB)
ANAB Lawsuit on behalf of: investors who purchased October 10, 2017 – November 7, 2019
Lead Plaintiff Deadline: May 26, 2020
Join the action: https://www.zlk.com/pslra-1/anaptysbio-inc-loss-form?wire=3&prid=5829

About the ANAB lawsuit: AnaptysBio, Inc. allegedly made materially false and/or misleading statements during the class period and/or failed to disclose that: (i) AnaptysBio failed to disseminate important data from the Company's Phase 2a trial in atopic dermatitis, including the timing and extent of patients' use of topical corticosteroids as a rescue therapy during the study and whether any of the patients that utilized rescue therapy were classified as responders at a given time;and (ii) the Company's statements omitted key information from the Company's Phase 2a trial in peanut allergy, including patients' average cumulative peanut dose tolerated at day 14 after the administration of etokimab or placebo as well as whether the Company's decision to exclude 20% of the patients enrolled in the study from the interim analysis due to their mild symptoms was retrospective; and (ii) as a result of the foregoing, Defendants' positive statements about the efficacy and prospects of AnaptysBio's lead drug asset in the treatment of atopic dermatitis and peanut allergy were materially false and/or misleading and/or lacked a reasonable basis.

To learn more about the AnaptysBio, Inc. class action, contact jlevi@levikorsinsky.com.

You have until the lead plaintiff deadlines to request the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 582832

SHAREHOLDER ALERT: TVTY CRON INO: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Tivity Health, Inc. (NASDAQ:TVTY)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/tivity-health-inc-loss-submission-form?prid=5826&wire=1
Lead Plaintiff Deadline: April 27, 2020
Class Period: March 8, 2019 to February 19, 2020

Allegations against TVTY include that: (i) following the Nutrisystem Acquisition, Tivity's Nutrition segment faced significant operational challenges; (ii) the foregoing would foreseeably have a significant impact on Tivity's revenues; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Cronos Group Inc. (NASDAQ:CRON)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/cronos-group-inc-loss-submission-form-2?prid=5826&wire=1
Lead Plaintiff Deadline: May 11, 2020
Class Period: May 9, 2019 to March 2, 2020

Allegations against CRON include that: (i) Cronos had engaged in significant transactions for which its revenue recognition was inappropriate; (ii) the foregoing would foreseeably necessitate reviews that would delay the Company's ability to timely file its periodic reports; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Inovio Pharmaceuticals, Inc. (NASDAQ:INO)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/inovio-pharmaceuticals-inc-loss-submission-form?prid=5826&wire=1
Lead Plaintiff Deadline: May 12, 2020
Class Period: February 14, 2020 to March 9, 2020

According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 582831

Jeff Nock, Iowa based Executive Consultant Explores Specific Key Concepts of Strategic Planning

Jeff Nock Outlines Key Concepts of Strategic Planning

IOWA CITY, IA / ACCESSWIRE / March 27, 2020 / Jeff Nock, Iowa based Executive Consultant and CEO and Founder of Prescient Consulting, LLC, further explores certain key elements of strategic planning. Specifically, he explains that the effectiveness of the strategic planning process goes beyond setting forth the business's vision for success and sustainability or communicating its purpose and value to customers, employees, and partners in a clear, concise manner.

The Jeff Nock Iowa business and executive consultancy firm works with a variety of companies. Founders in the startup space to leaders of established small and mid-cap companies lean on Jeff Nock Iowa based consultancy for advice and coaching assistance to excel and differentiate in their industry. An important step to unlocking long-term success is through the strategic planning process.

Strategic planning is pivotal to the long-term success of your company. Too many companies "wing it" day to day and may have short term success but ultimately they don't realize their potential because they didn't take the time to think about what that potential could be and how they can execute to achieve that potential. A good strategic plan is a living, dynamic process which projects the actions required to achieve potential. Understanding the important strategies and tactics of this plan and how to execute and measure success along the way provide a successful blueprint for any company.

You create a plan that captures the strategies that each area of your company will execute over prescribed periods of time (often quarterly-annual). Once these strategies are defined and assigned as lead responsibility to one leader per strategy, each strategy must define one or more Key Performance Indicators (KPIs). These KPIs will be measured in real-time or weekly whenever possible or monthly if necessary. For example, Sales could have a monthly KPI of $100,000 in revenue. For a mature organization that would be $25,000 per week. For a newer faster-growing company it might be $22,000 in week 1, $24,000 in week 2, $26,000 in week 3, and $28,000 in week 4.

Jeff Nock Iowa consultant explains the importance of planning and the important elements of your strategic plan

A saying of the Jeff Nock Iowa executive and business consultant company is that businesses who fail to plan, fail to know if they have succeeded. Moreover, plans that are written but never executed waste valuable time and resources. All this is to say that a strategic planning process for your business is an important first step. But the execution of that plan is more important.

Your plan is more than a collection of words on a piece of paper. They are the culmination of evaluating your internal core competencies, reading the market, identifying your niche, developing strategies to leverage those core competencies and executing on those strategies within your focused niche.

The important aspects of your company's strategic plan are:

Vision statement – This statement identifies what impact your company would have in a perfect world. Using Goodwill as an example, the vision of Goodwill is that all people with barriers to independence would have overcome those barriers and be living an abundant life.

Mission statement – Since we don't live in a perfect world, companies are not able to achieve their vision, so a Mission Statement is what they do to add value and for who. Using Goodwill as an example again, Goodwill's mission is to advance the well-being of people who experience barriers to independence.

To summarize using the Goodwill examples, many people are born with disabilities or have accidents that cause disabilities or experience other life challenges that cause them not to be able to maintain employment or basic social lives. The Goodwill vision is that all these people will overcome these issues and live great lives. The reality is that some disabilities can not be eliminated, so the vision will never be achieved. But the mission of advancing the well-being of these people is a clear beacon that enables all employees and stakeholders to stay focused on why they do the work they do and for who.

Culture Statement – a statement of shared beliefs and modes of behavior which define your workplace culture. People are motivated intrinsically and one of the top reasons that people excel and enjoy working with companies is because they align with and are motivated by the culture they work in. Culture statements should not be cliché statements like "work hard and earn profits." Founders, owners and CEOs should set the mark for the environment they want to or have established and ensure that people who are hired fit within that culture.

SWOT analysis – an important element of the strategic plan, a SWOT takes a look at your company's strengths-weaknesses (internal), and opportunities and threats (external). This can then be used to clarify core competencies so strategies can be identified to leverage those core competencies, a weakness which can be shored up, partnerships that can increase market share or address weaknesses, and competitive factors that can affect strategies like pricing and market locations.

Strategies These are the major company-initiatives that are the most important projects to complete during the prescribed timeframes within the plan. Each strategy must have one person accountable for leading the charge. The strategies must all align with the company mission.

Tactics (with key performance indicators or KPIs) – For each strategy, three or so tactics must be identified (similar to project planning) that will be executed to achieve the defined strategy.

Jeff Nock Iowa consultant on strategy setting

Strategy setting is an essential element for achieving of a company's potential. Companies who know what their mission is and take the time to think through what the most important strategies are to accomplish that mission are proven to be more successful than companies that merely work hard to achieve the opportunities that come up. One strategy setting methodology begins with a broad statement which uses bold words such as "enhance" or "empower." From these broad statements come enumerated objectives (i.e. Strategy 1, Tactics 1.1, 1.2, 1.3, etc.) which break down specific measurables for meeting the goal.

This drill down approach is important as it allows you to focus aspects of the strategy to the departments(s) accountable for achieving that strategy. For example, Jeff Nock Iowa leadership consultant explains a strategy such as "empowering patients to improve their healthcare outcomes" for a small medical practice could involve tactics such as:

– Improve technology interface for patients for scheduling and accessing/updating medical records.

– Increase availability and access for patients to 24/7.

– Waive fees associated with initial consultations and overhaul fee schedule for certain diagnostic tests to further reduce barriers to access.

You can see that within these three tactics related to Strategy #1 ("empowering patients to improve their healthcare outcomes"), the practice has drilled down enough to involve elements of its administrative staff, finance, and medical staff. This means responsibility has been assigned where appropriate.

Strategies are important aspects of the strategic plan. It is equally important to create meaningful tactics that relate best to the strategies you outline in the plan. With these tactics, you must create measurable KPIs that are sensible and best indicate progress toward the completion of a strategy and objective. In the example above, for tactic 1, a KPI could show a month-to-month positive change in the number of patient logins to access their personal health records over a period of 3 or 6 months. KPIs do not have to be complicated, just a SMART (Specific, Measurable, Attainable, Relevant, and Time-bound) metric useful in validating results.

Ongoing plan leadership according to Jeff Nock Iowa based business coaching CEO is essential

So often companies put months of time and energy into strategic planning, have a big launch party…and then go back to the same day to day activity. Nothing changes and strategies are not accomplished and potential mission fulfillment is not seen. A key to the successful execution of a leadership plan is a day to day leader within the company who is ultimately responsible for the completion of the plan. That person can either be the CEO or a COO type. This person must be both detail oriented and a motivator of people. As many founders and CEOs are visionary sales types and are more valuable in the market with customers or thinking ahead on upcoming strategies, sometimes the COO or Operations Director takes the point on strategic plan execution.

Ongoing communication is imperative in order to execute a good strategic plan. The plan leader should meet in regular intervals (weekly or monthly) to review KPI performance, celebrate success, address challenges, and iteratively adjust action where necessary. Department heads must then meet with each of their teams and make sure that each person in the company is completing work that is connected to the strategies and tactics of the overall plan. Each person must feel connected to the plan and feel they are making a contribution in order for the company to achieve its ultimate potential.

Another aspect of plan leadership for work teams is internal and external feedback. As defined by Jeff Nock Iowa based CEO for business advancement, feedback is the opportunity for customers and employees to send and receive positive (and critical) feedback from peers, supervisors, and others necessary to evaluate and improve performance. An example of how to gather customer feedback would be the Net Promoter Score (NPS). NPS is a third-party evaluation tool that allows customers to give their vendors feedback. Companies can then compare their score vs industry norms and celebrate or adjust accordingly.

Internal feedback can be conducted at the end of each project or time period. The 360 personnel review has been used for annual employee reviews but now more and more companies are taking the time to do a project review or quarterly review of their teams and the teams they work with. Done within a healthy culture (constructive feedback versus critical feedback) can result in great ongoing continuous improvement.

The integration of customer feedback with internal team communication benefits in the elimination of built-up frustration and enables the continuance of processes that are working and the adjustment of those that are not.

Setting mission focused strategies, thinking through and assigning SMART tactics that will enable those strategies to be achieved, and creating ongoing customer and internal team feedback results in the successful execution of well thought out strategic plans. This allows companies to work within a culture they enjoy, to achieve their potential, make their biggest impact on the world possible, and enable each employee to feel valued as contributors to the overall success of the company.

Contact:

Caroline Hunter|
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence, LLC

ReleaseID: 582830

Natural Cycles Launches COVID-19 Symptom Trackers In-App

Users everywhere will be able to log Coronavirus test results and track various symptoms

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Natural Cycles, the first and only FDA cleared birth control app, has released new functionality to help track users' symptoms if they feel sick and are experiencing potential COVID-19 symptoms.

The optional Natural Cycles trackers allow users to track their own symptoms in real time and share them with their healthcare provider. They will also be able to track a negative or positive COVID-19 test. Natural Cycles' dedicated research team may then be able to study the data in anonymized form to better understand the spread and the effects of the virus in different parts of the world.

Natural Cycles, which has over 1.5 million registered users across 162 countries, is powered by an algorithm that uses a woman's individual basal body temperature to determine her daily fertility status. Users are already taking their temperature each morning with their Natural Cycles thermometer and combining this temperature tracking already taking place with the COVID-19 symptom trackers will provide a unique opportunity in real time to follow the development of the virus.

The company has already seen a spike in temperature data being added over the past few weeks.

"The last few weeks we have been seeing changes in how our users use the app as the situation in the world is rapidly changing due to the new coronavirus," said Natural Cycles co-founder and CEO Elina Berglund. "We asked ourselves how we can better help our users, as well as the medical community, and immediately dedicated internal resources to release our COVID-19 symptom trackers functionality to users everywhere on an expedited timeline."

The trackers, which are optional and must be enabled by users, will join existing functionality that has served useful for users during this time. Natural Cycles is able to detect unusually elevated body temperature on an individual basis – potentially before it reaches a fever level- and automatically excludes it from the algorithm. If this happens, Natural Cycles sends users a message in the app to let them know.

While the trackers are provided for temporary documentation purposes only and are in no way intended to replace a professional medical diagnosis or treatment, Natural Cycles continues to work closely with healthcare professionals. The company donated hundreds of thermometers and subscriptions to healthcare workers on the frontline of the Coronavirus efforts for monitoring purposes. It has also already received inquiries from renowned third-party institutions looking for data of this kind to help support further research around Coronavirus.

For more information please reach out to press@naturalcycles.com

CONTACT:

Caroline Hunter
Web Presence, LLC
+1 7865519491

SOURCE: Web Presence, LLC

ReleaseID: 582825